Akumentis Healthcare Limited has launched Clasepi to combat epilepsy-related issues. Clasepi, a DCGI-approved prescription cannabidiol (CBD), is specifically developed to treat seizures caused by Lennox-Gastaut Syndrome (LGS), Dravet Syndrome, or...
At the Trade Policy Forum (TPF) meeting, India will strongly demand that the American health regulator expedite its USFDA inspections or audits of domestic pharmaceutical firms, lift the export ban on wild caught shrimp, and raise the issue of...
Transgen announced that they have signed an additional development cooperation agreement for personalized interventions. neoantigen cancer vaccine TG4050. TG4050 is currently being evaluated in a randomized multicenter phase I trial as a single...
Molecule AI, a pathfinder at the intersection of artificial intelligence and life sciences, today announces the debut of Molecule GEN, a game-changing platform destined to change AI-powered drug development. This disruptive Software-as-a-Service...
Isomorphic Labs, a digital biology firm on a goal to transform drug discovery through the use of artificial intelligence, announced a strategic research cooperation with Novartis to identify small molecule therapies against three undisclosed...
Novartis, a Swiss drugmaker, is reportedly in advanced talks to acquire Cytokinetics, an American biotechnology business. Novartis is anticipated to win the Cytokinetics auction, beating out competitors such as AstraZeneca and Johnson...
Cipla Ltd, a prominent pharmaceutical company, has formed a joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group to develop and commercialise innovative cell therapy products...
The Mayo Clinic, a nonprofit medical center in Rochester, Minnesota, has announced a partnership with Silicon Valley startup Cerebras Systems to build artificial intelligence (AI) models for the healthcare business. The Mayo Clinic, which has...
Gerresheimer, an innovative systems and solutions provider and global partner for the pharmaceutical, biotechnology, and cosmetics industries, and Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient...
Merck announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Harpoon for $23.00 per share in cash for an approximate total equity value of $680 million. “At Merck, we continue...
, CDSCO.jpg)
